Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Use of a simple pharmacokinetic model to characterize exposure to perchlorate

Journal of Exposure Science & Environmental Epidemiology volume 19, pages 260–273 (2009)Cite this article

Abstract

A simple two-compartment first-order pharmacokinetic model that predicts concentrations of perchlorate in blood and urine was constructed and validated. The model was validated using data from a high-dose experiment in humans where doses and resulting concentrations of perchlorate in blood and urine were well documented. Specifically, data were available for individuals who had been dosed at 0.5, 0.1, and 0.02 mg/kg/day for 14 consecutive days, significantly higher than the average background dose, which is estimated to be less than 0.0001 mg/kg/day. The average measured urine concentration in the high-dose regime during the experiment was 15.4 mg/l compared with an average prediction of 17.3 mg/l. In the medium-dose regime, the average measured was 3.0 mg/l compared with 4.1 mg/l predicted, and in the low-dose regime, the average measured was 0.53 mg/l compared with 0.68 mg/l predicted. For blood, the analogous results include 0.51 mg/l measured compared with 0.54 mg/l predicted in the high-dose regime and 0.12 mg/l measured versus 0.11 mg/l predicted in the medium-dose regime. The model was then used to study background exposures to perchlorate. A national sampling of perchlorate in urine showed a median concentration of 0.0035 mg/l, and this was used to back-calculate a dose of 0.000064 mg/kg/day. This finding was independently verified with the modeling structure of this study, as use of that back-calculated dose of 0.000064 mg/kg/day resulted in predictions of urine concentration with an average virtually identical at 0.0033 mg/l. An examination of literature data on the possible pathways of exposure suggests that the consumption of foods, rather than ingestion of water, dominates background exposures. Daily variation in urine concentration was studied with the model, and it was found that concentrations in the morning hours were lower than concentrations in the afternoon and evening hours, corresponding to the time when most exposure was assumed to occur.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Aylward L.L., Brunet R.C., Carrier G., Hays S.M., Cushing C.A., Needham L.L., Patterson D.G., Gerthoux P.M., Brambilla P., and Mocarelli P. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults form Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Exp Anal Environ Epi 2005: 15: 51–65.

    Article  CAS  Google Scholar 

  • Blount B.C., Valentin-Blasini L., Osterloh J.D., Mauldin J.P., and Pirkle J.L. Perchlorate exposure of the US population, 2001–2002. J Exp Sci Env Epi 2007: 17: 400–407.

    Article  CAS  Google Scholar 

  • Braverman L.E., Pearce E.N., He X., Pino S., Seeley M., Beck B., Magnani B., Blount B.C., and Fireket A. Effects of six months of daily low-dose perchlorate exposure on thyroid function in healthy volunteers. J Clin Endocrinol Metab 2006: 91: 2721–2724.

    Article  CAS  Google Scholar 

  • CA DHS. California Department of Health Services. “Perchlorate in California Drinking Water: Monitoring Update.” 2006. Available at: http://www.dhs.ca.gov/ps/ddwem/chemicals/perchl/monitoringupdate.htm.

  • Clewell R.A., Merrill E.A., Gearhart J.M., Robinson P.J., Sterner T.R., Mattie D.R., and Clewell H.J. Perchlorate and radioiodide kinetics across life stages in the human: using PBPK models to predict dosimetry and thyroid inhibition and sensitive subpopulations based on developmental stage. J Tox Env Health, Part A 2007: 70: 408–428.

    Article  CAS  Google Scholar 

  • Clewell R.A., Merrill E.A., Yu K.O., Mahle D.A., Sterner T.R., Fisher J.W., and Gearhart J.M. Predicting neonatal perchlorate dose and inhibition of iodide kinetics in the rat during lactation using physiologically based pharmacokinetic modeling. Toxicol Sci 2003: 74: 416–436.

    Article  CAS  Google Scholar 

  • Cockroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976: 16: 31–41.

    Article  Google Scholar 

  • Crump K.S., and Gibbs J.P. Benchmark calculations for perchlorate from three human cohorts. Env Health Persp 2005: 113: 1001–1008.

    Article  CAS  Google Scholar 

  • EPA. Exposure Factors Handbook. United States Environmental Protection Agency, Office of Research and Development, Washington, DC. EPA/600/P-95/002B. 1997.

  • EPA. Child-Specific Exposure Factors Handbook (External Review Draft). National Center for Environmental Assessment, Office of Research and Development, US EPA., EPA/600/R/06/096A. 2006 September 2006. Available at, http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=56747.

  • EPA. Drinking Water: Regulatory Determinations Regarding Contaminants on the Second Drinking Water Contaminant Candidate List—Preliminary Determinations; Proposed Rule. Federal Register Notice. Vol. 72, No. 83, published Tuesday, May 1, 2007, pp. 24015–24058.

  • FDA. 2004–2005 Exploratory Survey Data on Perchlorate in Food. Posted May, 2007. Accessed July 15, 2007. http://www.cfsan.fda.gov/~dms/clo4data.html.

  • Greer M.A., Goodman G., Pleus R.C., and Greer S.E. Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Env Health Persp 2002: 110: 927–937.

    Article  CAS  Google Scholar 

  • IRIS. Integrated Risk Information System. Perchlorate and Perchlorate Salts. IRIS entry accessed July 25, 2007. http://www.epa.gov/iris/subst/1007.htm.

  • Kirk A.B., Dyke J.V., Martin C.F., and Dasgupta P.K. Temporal patterns in perchlorate thiocyanate, and iodide excretion in human milk. Env Health Persp 2007: 115: 182–186.

    Article  CAS  Google Scholar 

  • Kirk A.B., Martinelango P.K., Tian K., Dutta A., Smith E.E., and Dasgupta P.K. Perchlorate and iodide in dairy and breast milk. Env Sci Tech 2005: 39: 2011–2017.

    Article  CAS  Google Scholar 

  • Lawrence J.E., Lamm S.H., Pino S., Richman K., and Braverman L.E. The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid 2000: 10: 659–663.

    Article  CAS  Google Scholar 

  • Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J Exp Sci Environ Epidemiol 2008: 18: 2–19.

    Article  CAS  Google Scholar 

  • Lorber M. A pharmacokinetic model for estimating exposure of Americans to dioxin-like compounds in the past, present, and future. Sci Total Env 2002: 288: 81–95.

    Article  CAS  Google Scholar 

  • MA DEP. Massachusetts Department of Environmental Protection. The Occurrence and Sources of Perchlorate in Massachusetts. Draft Report. 2006 Available at: http://www.mass.gov/dep/cleanup/sites/percsour.pdf. Updated April 2006.

  • Mage D.T., Allen R.H., Gondy G., Smith W., Barr D.B., and Needham L.L. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J Expo Anal Environ Epidemiol 2004: 14: 457–465.

    Article  CAS  Google Scholar 

  • Merrill E. Memorandum from E. Merrill to A Jarabek dated 10 May 2001 titled, “Consultative Letter, AFRL-HE-WP-CL-2001-0004, QA/QC Audit Report for the Study of Perchlorate Pharmacokinetics and Inhibition of Radioactive Iodine Update (RAIU) by the Thyroid in Humans (CRC Protocol no. 628)”. 2001. Available at, http://www.epa.gov/ncea/perchlorate/references2/.

  • Merrill E.A., Clewell R.A., Robinson P.J., Jarabek A.M., Gearhart J.M., Sterner T.R., Yu K.O., and Fisher J.W. PBPK model for radioactive iodide and perchlorate kinetics and the perchlorate-induced inhibition of iodide uptake in humans. Toxicol Sci 2005: 83: 25–43.

    Article  CAS  Google Scholar 

  • Murray C.W., Egan S.K., Kim H., Beru N., and Bolger P.M. US Food and Drug Administration's Total Diet Study: dietary intake of perchlorate and iodine. J Exp Sci Environ Epidemiol 2008; advance online publication 2 January 2008; doi: 10.1038/sj.jes.7500648.

    Article  CAS  Google Scholar 

  • Narayanan L., Buttler G.W., Yu K.O., Mattie D.R., and Fisher J.W. Sensitive high-performance liquid chromatography method for the determination of low levels of perchlorate in biological samples. J Chromatogr B 2003: 788: 393–399.

    Article  CAS  Google Scholar 

  • NAS. National Academy of Sciences. Health Implications of Perchlorate Ingestion. National Academies Press, Washington, DC, 2005.

  • Pearce E.N., Leung A.M., Blount B.C., Bazrafshan H.R., He X., Pino S., Valentin-Blasini L., and Braverman L.E. Breast milk iodine and perchlorate concentrations in lactating Boston-area women. J Clin Endocrin Metab 2007: 92: 1673–1677.

    Article  CAS  Google Scholar 

  • Tellez R.T., Chacon P.M., Abarca C.R., Blount B.C., Van Landingham C.B., Crump K.S., and Gibbs J.P. Chronic environmental exposure to perchlorate through drinking water and thyroid function during pregnancy and in the neonatal period. Thyroid 2005: 15: 963–975.

    Article  CAS  Google Scholar 

  • Valentin-Blasini L., Mauldin J.P., Maple D., and Blount B.C. Analysis of perchlorate in human urine using ion chromatography and electrospray tandem mass spectrometry. Anal Chem 2005: 77: 2475–2481.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

I am indebted to the direction, helpful comments, and insights provided by Elizabeth Doyle, Eric Burneson, Derek Losh, Michael Devito, and Lynn Flowers of EPA, and the same provided by Elaine Merrill of the United States Air Force.

Author information

Authors and Affiliations

  1. Office of Research and Development, United States Environmental Protection Agency, 1200 Pennsylvania Ave, Washington, 20460, District of Columbia, USA

    Matthew Lorber

Authors
  1. Matthew Lorber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew Lorber.

Additional information

Disclaimer

The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the US Environmental Protection Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorber, M. Use of a simple pharmacokinetic model to characterize exposure to perchlorate. J Expo Sci Environ Epidemiol 19, 260–273 (2009). https://doi.org/10.1038/jes.2008.8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jes.2008.8

Keywords

This article is cited by

Search

Advanced search

Quick links